Table 1.

Patient Characteristics and Engraftment in SCID Mice

Patient No.Age (yr)/SexWCC (×109/L)Patient OutcomeSurvival (mo)Sample Injected in SCIDPresentationLeukemia in SCID
or Relapse
Sample Injected
 
T1 5/F 191 A: 2nd CR 50  PB, cryo − 
T2 17/M 65 D:T 3  PB, fresh 
T3 17/F 282 A: 1st CR 42  PB, cryo − 
T4 21/M 900 D:L 12  PB, cryo 
T5 31/M 248 D:L 16  PB, cryo 
T6 22/M 54 D:L 1  PB, fresh 
T7 22/M 602 A: 1st CR 18  PB, fresh 
T8 14/M 490 D:L 4  PB, cryo 
T9 16/M 97 D:T 57  BM, cryo 
T10 18/M 224 D:L 18  PB, cryo 
T11 5/F 202 D:T 6  PB, cryo − 
T12 24/M 263 D:L 11  PB, cryo 
T13 40/M 64 D:T 0.5 PB, cryo − 
T14 19/M 34 D:T 6  BM, cryo 
T15 23/M 26 A: 1st CR 124  PB, cryo − 
T16 23/M 595 D:L 6  PB, cryo 
T17 8/M 121 A: 1st CR 57  PB, cryo − 
T18 23/M 231 D:L 10  PB, cryo 
T19 21/M 18 A: 1st CR 21  PB, cryo − 
Patient No.Age (yr)/SexWCC (×109/L)Patient OutcomeSurvival (mo)Sample Injected in SCIDPresentationLeukemia in SCID
or Relapse
Sample Injected
 
T1 5/F 191 A: 2nd CR 50  PB, cryo − 
T2 17/M 65 D:T 3  PB, fresh 
T3 17/F 282 A: 1st CR 42  PB, cryo − 
T4 21/M 900 D:L 12  PB, cryo 
T5 31/M 248 D:L 16  PB, cryo 
T6 22/M 54 D:L 1  PB, fresh 
T7 22/M 602 A: 1st CR 18  PB, fresh 
T8 14/M 490 D:L 4  PB, cryo 
T9 16/M 97 D:T 57  BM, cryo 
T10 18/M 224 D:L 18  PB, cryo 
T11 5/F 202 D:T 6  PB, cryo − 
T12 24/M 263 D:L 11  PB, cryo 
T13 40/M 64 D:T 0.5 PB, cryo − 
T14 19/M 34 D:T 6  BM, cryo 
T15 23/M 26 A: 1st CR 124  PB, cryo − 
T16 23/M 595 D:L 6  PB, cryo 
T17 8/M 121 A: 1st CR 57  PB, cryo − 
T18 23/M 231 D:L 10  PB, cryo 
T19 21/M 18 A: 1st CR 21  PB, cryo − 

Abbreviations: WCC, white blood cell count; P, presentation; R, relapse; A, alive; D, dead; T, death related to toxicity of treatment; L, death due to leukemia; cryo, cryopreserved; +, engraftment in SCID mice; −, no engraftment in SCID mice.

or Create an Account

Close Modal
Close Modal